These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 8991066

  • 1. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR, Kort KL, Marino DR, Mittal LV, Umbenhauer DR, Laws GM, Adams SP.
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [Abstract] [Full Text] [Related]

  • 2. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L, Saranko CJ, Steen AM.
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR, Gorelick NJ, Andrews JL, de Boer JG, Glickman BW.
    Environ Mol Mutagen; 1996 Mar; 28(4):385-92. PubMed ID: 8991067
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH, Smith LE, Feng Z, Tang M, Lee CS, Pfeifer GP.
    Cancer Res; 2001 Oct 01; 61(19):7110-7. PubMed ID: 11585742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE, Meng Q.
    Res Rep Health Eff Inst; 2000 Mar 01; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [Abstract] [Full Text] [Related]

  • 11. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME, Kabler SL, Fleming MH, Ravoori S, Gupta RC, Doehmer J, Morrow CS, Townsend AJ.
    Carcinogenesis; 2007 Jan 01; 28(1):207-14. PubMed ID: 16885195
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W, Ahiabor R, Blanco B, Locher F, Mantovani F, Robinson M, Sreenan G, Staedtler F, Swingler T, Vignutelli A, Perentes E.
    Environ Mol Mutagen; 1996 Jan 01; 28(4):354-62. PubMed ID: 8991064
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
    Walker VE, Sisk SC, Upton PB, Wong BA, Recio L.
    Mutat Res; 1997 Aug 14; 392(3):211-22. PubMed ID: 9294020
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
    Bol SA, van Steeg H, Jansen JG, Van Oostrom C, de Vries A, de Groot AJ, Tates AD, Vrieling H, van Zeeland AA, Mullenders LH.
    Cancer Res; 1998 Jul 01; 58(13):2850-6. PubMed ID: 9661901
    [Abstract] [Full Text] [Related]

  • 17. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
    Wijnhoven SW, Kool HJ, van Oostrom CT, Beems RB, Mullenders LH, van Zeeland AA, van der Horst GT, Vrieling H, van Steeg H.
    Cancer Res; 2000 Oct 15; 60(20):5681-7. PubMed ID: 11059760
    [Abstract] [Full Text] [Related]

  • 18. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA.
    Res Rep Health Eff Inst; 1995 Oct 15; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [Abstract] [Full Text] [Related]

  • 19. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL, Atherholt TB.
    Cancer Res; 1990 Feb 15; 50(4):1189-94. PubMed ID: 2105163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.